Christian Dowdeswell, managing director, featured in European Pharmaceutical Manufacturer.
As 2026 approaches, European Pharmaceutical Manufacturer asked industry leaders to share their predictions—from breakthroughs in AI and innovation to evolving regulations and building resilience.
"Expect more complex synthetic pathways driven by AI enabled drug discovery..."
Read Christian's full prediction and explore insights from other industry experts here.
Credit:
European Pharmaceutical Manufacturer, Pharmaceutical Insights